nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadofosveset trisodium—ALB—Vandetanib—thyroid cancer	0.542	1	CbGbCtD
Gadofosveset trisodium—Injection site pain—Doxorubicin—thyroid cancer	0.00127	0.00276	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Vandetanib—thyroid cancer	0.00127	0.00276	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Vandetanib—thyroid cancer	0.00127	0.00276	CcSEcCtD
Gadofosveset trisodium—Cellulitis—Epirubicin—thyroid cancer	0.00123	0.00268	CcSEcCtD
Gadofosveset trisodium—Hypocalcaemia—Epirubicin—thyroid cancer	0.00122	0.00266	CcSEcCtD
Gadofosveset trisodium—Lacrimation increased—Epirubicin—thyroid cancer	0.00121	0.00265	CcSEcCtD
Gadofosveset trisodium—Oliguria—Epirubicin—thyroid cancer	0.00121	0.00265	CcSEcCtD
Gadofosveset trisodium—Syncope—Sorafenib—thyroid cancer	0.00119	0.00259	CcSEcCtD
Gadofosveset trisodium—Extravasation—Doxorubicin—thyroid cancer	0.00119	0.00259	CcSEcCtD
Gadofosveset trisodium—Ulcer—Epirubicin—thyroid cancer	0.00118	0.00258	CcSEcCtD
Gadofosveset trisodium—Creatinine increased—Epirubicin—thyroid cancer	0.00118	0.00256	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Sorafenib—thyroid cancer	0.00116	0.00254	CcSEcCtD
Gadofosveset trisodium—Cough—Sorafenib—thyroid cancer	0.00115	0.00252	CcSEcCtD
Gadofosveset trisodium—Asthenia—Vandetanib—thyroid cancer	0.00115	0.00251	CcSEcCtD
Gadofosveset trisodium—Hypertension—Sorafenib—thyroid cancer	0.00114	0.00249	CcSEcCtD
Gadofosveset trisodium—Cellulitis—Doxorubicin—thyroid cancer	0.00114	0.00248	CcSEcCtD
Gadofosveset trisodium—Pruritus—Vandetanib—thyroid cancer	0.00113	0.00247	CcSEcCtD
Gadofosveset trisodium—Neck pain—Epirubicin—thyroid cancer	0.00113	0.00247	CcSEcCtD
Gadofosveset trisodium—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00113	0.00247	CcSEcCtD
Gadofosveset trisodium—Lacrimation increased—Doxorubicin—thyroid cancer	0.00112	0.00245	CcSEcCtD
Gadofosveset trisodium—Oliguria—Doxorubicin—thyroid cancer	0.00112	0.00245	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00112	0.00244	CcSEcCtD
Gadofosveset trisodium—Abnormal dreams—Epirubicin—thyroid cancer	0.00111	0.00241	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Sorafenib—thyroid cancer	0.0011	0.0024	CcSEcCtD
Gadofosveset trisodium—Hyperkalaemia—Epirubicin—thyroid cancer	0.0011	0.0024	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Vandetanib—thyroid cancer	0.0011	0.00239	CcSEcCtD
Gadofosveset trisodium—Ulcer—Doxorubicin—thyroid cancer	0.00109	0.00239	CcSEcCtD
Gadofosveset trisodium—Creatinine increased—Doxorubicin—thyroid cancer	0.00109	0.00237	CcSEcCtD
Gadofosveset trisodium—Salivary hypersecretion—Epirubicin—thyroid cancer	0.00109	0.00237	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Sorafenib—thyroid cancer	0.00108	0.00236	CcSEcCtD
Gadofosveset trisodium—Infection—Sorafenib—thyroid cancer	0.00107	0.00234	CcSEcCtD
Gadofosveset trisodium—Shock—Sorafenib—thyroid cancer	0.00106	0.00232	CcSEcCtD
Gadofosveset trisodium—Fluid retention—Epirubicin—thyroid cancer	0.00106	0.00232	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Sorafenib—thyroid cancer	0.00106	0.00231	CcSEcCtD
Gadofosveset trisodium—Dizziness—Vandetanib—thyroid cancer	0.00106	0.00231	CcSEcCtD
Gadofosveset trisodium—Blood urea increased—Epirubicin—thyroid cancer	0.00106	0.0023	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Sorafenib—thyroid cancer	0.00105	0.00229	CcSEcCtD
Gadofosveset trisodium—Neck pain—Doxorubicin—thyroid cancer	0.00105	0.00228	CcSEcCtD
Gadofosveset trisodium—Anorexia—Sorafenib—thyroid cancer	0.00103	0.00225	CcSEcCtD
Gadofosveset trisodium—Abnormal dreams—Doxorubicin—thyroid cancer	0.00102	0.00223	CcSEcCtD
Gadofosveset trisodium—Vomiting—Vandetanib—thyroid cancer	0.00102	0.00222	CcSEcCtD
Gadofosveset trisodium—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00102	0.00222	CcSEcCtD
Gadofosveset trisodium—Rash—Vandetanib—thyroid cancer	0.00101	0.0022	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Vandetanib—thyroid cancer	0.00101	0.0022	CcSEcCtD
Gadofosveset trisodium—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00101	0.00219	CcSEcCtD
Gadofosveset trisodium—Headache—Vandetanib—thyroid cancer	0.001	0.00219	CcSEcCtD
Gadofosveset trisodium—Fluid retention—Doxorubicin—thyroid cancer	0.000983	0.00214	CcSEcCtD
Gadofosveset trisodium—Blood urea increased—Doxorubicin—thyroid cancer	0.000977	0.00213	CcSEcCtD
Gadofosveset trisodium—Abnormal vision—Epirubicin—thyroid cancer	0.000976	0.00213	CcSEcCtD
Gadofosveset trisodium—Sepsis—Epirubicin—thyroid cancer	0.000971	0.00212	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Sorafenib—thyroid cancer	0.000963	0.0021	CcSEcCtD
Gadofosveset trisodium—Nausea—Vandetanib—thyroid cancer	0.000951	0.00207	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Sorafenib—thyroid cancer	0.000951	0.00207	CcSEcCtD
Gadofosveset trisodium—Phlebitis—Epirubicin—thyroid cancer	0.000942	0.00206	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Sorafenib—thyroid cancer	0.000939	0.00205	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000932	0.00203	CcSEcCtD
Gadofosveset trisodium—Fatigue—Sorafenib—thyroid cancer	0.000931	0.00203	CcSEcCtD
Gadofosveset trisodium—Pain—Sorafenib—thyroid cancer	0.000923	0.00201	CcSEcCtD
Gadofosveset trisodium—Constipation—Sorafenib—thyroid cancer	0.000923	0.00201	CcSEcCtD
Gadofosveset trisodium—Abnormal vision—Doxorubicin—thyroid cancer	0.000903	0.00197	CcSEcCtD
Gadofosveset trisodium—Sepsis—Doxorubicin—thyroid cancer	0.000898	0.00196	CcSEcCtD
Gadofosveset trisodium—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000895	0.00195	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000883	0.00193	CcSEcCtD
Gadofosveset trisodium—Renal failure acute—Epirubicin—thyroid cancer	0.000879	0.00192	CcSEcCtD
Gadofosveset trisodium—Phlebitis—Doxorubicin—thyroid cancer	0.000872	0.0019	CcSEcCtD
Gadofosveset trisodium—Urticaria—Sorafenib—thyroid cancer	0.000858	0.00187	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Sorafenib—thyroid cancer	0.000854	0.00186	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Sorafenib—thyroid cancer	0.000854	0.00186	CcSEcCtD
Gadofosveset trisodium—Renal impairment—Epirubicin—thyroid cancer	0.000853	0.00186	CcSEcCtD
Gadofosveset trisodium—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000839	0.00183	CcSEcCtD
Gadofosveset trisodium—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000829	0.00181	CcSEcCtD
Gadofosveset trisodium—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000828	0.00181	CcSEcCtD
Gadofosveset trisodium—Hyponatraemia—Epirubicin—thyroid cancer	0.000815	0.00178	CcSEcCtD
Gadofosveset trisodium—Renal failure acute—Doxorubicin—thyroid cancer	0.000814	0.00177	CcSEcCtD
Gadofosveset trisodium—Pain in extremity—Epirubicin—thyroid cancer	0.000812	0.00177	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Sorafenib—thyroid cancer	0.000796	0.00174	CcSEcCtD
Gadofosveset trisodium—Renal impairment—Doxorubicin—thyroid cancer	0.000789	0.00172	CcSEcCtD
Gadofosveset trisodium—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000776	0.00169	CcSEcCtD
Gadofosveset trisodium—Asthenia—Sorafenib—thyroid cancer	0.000775	0.00169	CcSEcCtD
Gadofosveset trisodium—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000767	0.00167	CcSEcCtD
Gadofosveset trisodium—Pruritus—Sorafenib—thyroid cancer	0.000764	0.00167	CcSEcCtD
Gadofosveset trisodium—Blood creatinine increased—Epirubicin—thyroid cancer	0.000761	0.00166	CcSEcCtD
Gadofosveset trisodium—Dehydration—Epirubicin—thyroid cancer	0.000755	0.00165	CcSEcCtD
Gadofosveset trisodium—Hyponatraemia—Doxorubicin—thyroid cancer	0.000754	0.00165	CcSEcCtD
Gadofosveset trisodium—Pain in extremity—Doxorubicin—thyroid cancer	0.000751	0.00164	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Epirubicin—thyroid cancer	0.000739	0.00161	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Sorafenib—thyroid cancer	0.000739	0.00161	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Epirubicin—thyroid cancer	0.000734	0.0016	CcSEcCtD
Gadofosveset trisodium—Nasopharyngitis—Epirubicin—thyroid cancer	0.000726	0.00158	CcSEcCtD
Gadofosveset trisodium—Dizziness—Sorafenib—thyroid cancer	0.000714	0.00156	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Epirubicin—thyroid cancer	0.000706	0.00154	CcSEcCtD
Gadofosveset trisodium—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000704	0.00154	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Epirubicin—thyroid cancer	0.000702	0.00153	CcSEcCtD
Gadofosveset trisodium—Dehydration—Doxorubicin—thyroid cancer	0.000699	0.00152	CcSEcCtD
Gadofosveset trisodium—Vomiting—Sorafenib—thyroid cancer	0.000687	0.0015	CcSEcCtD
Gadofosveset trisodium—Hypokalaemia—Doxorubicin—thyroid cancer	0.000684	0.00149	CcSEcCtD
Gadofosveset trisodium—Rash—Sorafenib—thyroid cancer	0.000681	0.00149	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Sorafenib—thyroid cancer	0.00068	0.00148	CcSEcCtD
Gadofosveset trisodium—Breast disorder—Doxorubicin—thyroid cancer	0.000679	0.00148	CcSEcCtD
Gadofosveset trisodium—Headache—Sorafenib—thyroid cancer	0.000676	0.00148	CcSEcCtD
Gadofosveset trisodium—Bronchitis—Epirubicin—thyroid cancer	0.000675	0.00147	CcSEcCtD
Gadofosveset trisodium—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000672	0.00147	CcSEcCtD
Gadofosveset trisodium—Abdominal distension—Doxorubicin—thyroid cancer	0.000654	0.00143	CcSEcCtD
Gadofosveset trisodium—Dysphagia—Doxorubicin—thyroid cancer	0.000649	0.00142	CcSEcCtD
Gadofosveset trisodium—Pollakiuria—Epirubicin—thyroid cancer	0.000648	0.00141	CcSEcCtD
Gadofosveset trisodium—Nausea—Sorafenib—thyroid cancer	0.000641	0.0014	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Epirubicin—thyroid cancer	0.000633	0.00138	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Epirubicin—thyroid cancer	0.000626	0.00136	CcSEcCtD
Gadofosveset trisodium—Infestation—Epirubicin—thyroid cancer	0.000626	0.00136	CcSEcCtD
Gadofosveset trisodium—Bronchitis—Doxorubicin—thyroid cancer	0.000624	0.00136	CcSEcCtD
Gadofosveset trisodium—Renal failure—Epirubicin—thyroid cancer	0.000615	0.00134	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Epirubicin—thyroid cancer	0.000608	0.00133	CcSEcCtD
Gadofosveset trisodium—Pollakiuria—Doxorubicin—thyroid cancer	0.0006	0.00131	CcSEcCtD
Gadofosveset trisodium—Haematuria—Epirubicin—thyroid cancer	0.000597	0.0013	CcSEcCtD
Gadofosveset trisodium—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000586	0.00128	CcSEcCtD
Gadofosveset trisodium—Infestation NOS—Doxorubicin—thyroid cancer	0.000579	0.00126	CcSEcCtD
Gadofosveset trisodium—Infestation—Doxorubicin—thyroid cancer	0.000579	0.00126	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Epirubicin—thyroid cancer	0.000572	0.00125	CcSEcCtD
Gadofosveset trisodium—Renal failure—Doxorubicin—thyroid cancer	0.000569	0.00124	CcSEcCtD
Gadofosveset trisodium—Urinary tract infection—Doxorubicin—thyroid cancer	0.000563	0.00123	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Epirubicin—thyroid cancer	0.000559	0.00122	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Epirubicin—thyroid cancer	0.000555	0.00121	CcSEcCtD
Gadofosveset trisodium—Haematuria—Doxorubicin—thyroid cancer	0.000552	0.0012	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Epirubicin—thyroid cancer	0.000552	0.0012	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Epirubicin—thyroid cancer	0.000551	0.0012	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Epirubicin—thyroid cancer	0.000541	0.00118	CcSEcCtD
Gadofosveset trisodium—Bradycardia—Doxorubicin—thyroid cancer	0.000529	0.00115	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Epirubicin—thyroid cancer	0.000525	0.00114	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Epirubicin—thyroid cancer	0.000521	0.00114	CcSEcCtD
Gadofosveset trisodium—Flushing—Epirubicin—thyroid cancer	0.000521	0.00114	CcSEcCtD
Gadofosveset trisodium—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000517	0.00113	CcSEcCtD
Gadofosveset trisodium—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000513	0.00112	CcSEcCtD
Gadofosveset trisodium—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000511	0.00111	CcSEcCtD
Gadofosveset trisodium—Urethral disorder—Doxorubicin—thyroid cancer	0.000509	0.00111	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Epirubicin—thyroid cancer	0.000507	0.00111	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Epirubicin—thyroid cancer	0.000506	0.0011	CcSEcCtD
Gadofosveset trisodium—Chills—Epirubicin—thyroid cancer	0.000504	0.0011	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Epirubicin—thyroid cancer	0.000502	0.00109	CcSEcCtD
Gadofosveset trisodium—Visual impairment—Doxorubicin—thyroid cancer	0.000501	0.00109	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Epirubicin—thyroid cancer	0.000492	0.00107	CcSEcCtD
Gadofosveset trisodium—Erythema—Epirubicin—thyroid cancer	0.000489	0.00107	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Epirubicin—thyroid cancer	0.000489	0.00107	CcSEcCtD
Gadofosveset trisodium—Eye disorder—Doxorubicin—thyroid cancer	0.000486	0.00106	CcSEcCtD
Gadofosveset trisodium—Flushing—Doxorubicin—thyroid cancer	0.000482	0.00105	CcSEcCtD
Gadofosveset trisodium—Cardiac disorder—Doxorubicin—thyroid cancer	0.000482	0.00105	CcSEcCtD
Gadofosveset trisodium—Flatulence—Epirubicin—thyroid cancer	0.000482	0.00105	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Epirubicin—thyroid cancer	0.000479	0.00104	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Epirubicin—thyroid cancer	0.00047	0.00103	CcSEcCtD
Gadofosveset trisodium—Immune system disorder—Doxorubicin—thyroid cancer	0.000469	0.00102	CcSEcCtD
Gadofosveset trisodium—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000468	0.00102	CcSEcCtD
Gadofosveset trisodium—Chills—Doxorubicin—thyroid cancer	0.000466	0.00102	CcSEcCtD
Gadofosveset trisodium—Arrhythmia—Doxorubicin—thyroid cancer	0.000464	0.00101	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Epirubicin—thyroid cancer	0.000461	0.00101	CcSEcCtD
Gadofosveset trisodium—Mental disorder—Doxorubicin—thyroid cancer	0.000455	0.000993	CcSEcCtD
Gadofosveset trisodium—Malnutrition—Doxorubicin—thyroid cancer	0.000452	0.000987	CcSEcCtD
Gadofosveset trisodium—Erythema—Doxorubicin—thyroid cancer	0.000452	0.000987	CcSEcCtD
Gadofosveset trisodium—Flatulence—Doxorubicin—thyroid cancer	0.000446	0.000972	CcSEcCtD
Gadofosveset trisodium—Dysgeusia—Doxorubicin—thyroid cancer	0.000443	0.000966	CcSEcCtD
Gadofosveset trisodium—Vertigo—Epirubicin—thyroid cancer	0.000439	0.000958	CcSEcCtD
Gadofosveset trisodium—Syncope—Epirubicin—thyroid cancer	0.000438	0.000956	CcSEcCtD
Gadofosveset trisodium—Muscle spasms—Doxorubicin—thyroid cancer	0.000435	0.000949	CcSEcCtD
Gadofosveset trisodium—Palpitations—Epirubicin—thyroid cancer	0.000432	0.000942	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Epirubicin—thyroid cancer	0.00043	0.000937	CcSEcCtD
Gadofosveset trisodium—Cough—Epirubicin—thyroid cancer	0.000427	0.000931	CcSEcCtD
Gadofosveset trisodium—Vision blurred—Doxorubicin—thyroid cancer	0.000426	0.00093	CcSEcCtD
Gadofosveset trisodium—Convulsion—Epirubicin—thyroid cancer	0.000424	0.000924	CcSEcCtD
Gadofosveset trisodium—Hypertension—Epirubicin—thyroid cancer	0.000422	0.000921	CcSEcCtD
Gadofosveset trisodium—Chest pain—Epirubicin—thyroid cancer	0.000416	0.000908	CcSEcCtD
Gadofosveset trisodium—Anxiety—Epirubicin—thyroid cancer	0.000415	0.000905	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000413	0.000902	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Epirubicin—thyroid cancer	0.000407	0.000888	CcSEcCtD
Gadofosveset trisodium—Vertigo—Doxorubicin—thyroid cancer	0.000406	0.000887	CcSEcCtD
Gadofosveset trisodium—Syncope—Doxorubicin—thyroid cancer	0.000406	0.000885	CcSEcCtD
Gadofosveset trisodium—Confusional state—Epirubicin—thyroid cancer	0.000402	0.000878	CcSEcCtD
Gadofosveset trisodium—Palpitations—Doxorubicin—thyroid cancer	0.0004	0.000872	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Epirubicin—thyroid cancer	0.000399	0.00087	CcSEcCtD
Gadofosveset trisodium—Oedema—Epirubicin—thyroid cancer	0.000399	0.00087	CcSEcCtD
Gadofosveset trisodium—Loss of consciousness—Doxorubicin—thyroid cancer	0.000398	0.000867	CcSEcCtD
Gadofosveset trisodium—Infection—Epirubicin—thyroid cancer	0.000396	0.000865	CcSEcCtD
Gadofosveset trisodium—Cough—Doxorubicin—thyroid cancer	0.000395	0.000861	CcSEcCtD
Gadofosveset trisodium—Shock—Epirubicin—thyroid cancer	0.000393	0.000856	CcSEcCtD
Gadofosveset trisodium—Convulsion—Doxorubicin—thyroid cancer	0.000392	0.000855	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Epirubicin—thyroid cancer	0.000391	0.000854	CcSEcCtD
Gadofosveset trisodium—Hypertension—Doxorubicin—thyroid cancer	0.000391	0.000852	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Epirubicin—thyroid cancer	0.000389	0.00085	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Epirubicin—thyroid cancer	0.000388	0.000845	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Epirubicin—thyroid cancer	0.000386	0.000841	CcSEcCtD
Gadofosveset trisodium—Chest pain—Doxorubicin—thyroid cancer	0.000385	0.00084	CcSEcCtD
Gadofosveset trisodium—Anxiety—Doxorubicin—thyroid cancer	0.000384	0.000837	CcSEcCtD
Gadofosveset trisodium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000383	0.000834	CcSEcCtD
Gadofosveset trisodium—Anorexia—Epirubicin—thyroid cancer	0.00038	0.00083	CcSEcCtD
Gadofosveset trisodium—Dry mouth—Doxorubicin—thyroid cancer	0.000377	0.000822	CcSEcCtD
Gadofosveset trisodium—Hypotension—Epirubicin—thyroid cancer	0.000373	0.000813	CcSEcCtD
Gadofosveset trisodium—Confusional state—Doxorubicin—thyroid cancer	0.000372	0.000812	CcSEcCtD
Gadofosveset trisodium—Oedema—Doxorubicin—thyroid cancer	0.000369	0.000805	CcSEcCtD
Gadofosveset trisodium—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000369	0.000805	CcSEcCtD
Gadofosveset trisodium—Infection—Doxorubicin—thyroid cancer	0.000367	0.0008	CcSEcCtD
Gadofosveset trisodium—Shock—Doxorubicin—thyroid cancer	0.000363	0.000792	CcSEcCtD
Gadofosveset trisodium—Nervous system disorder—Doxorubicin—thyroid cancer	0.000362	0.00079	CcSEcCtD
Gadofosveset trisodium—Tachycardia—Doxorubicin—thyroid cancer	0.00036	0.000786	CcSEcCtD
Gadofosveset trisodium—Skin disorder—Doxorubicin—thyroid cancer	0.000359	0.000782	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Epirubicin—thyroid cancer	0.000358	0.000782	CcSEcCtD
Gadofosveset trisodium—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000357	0.000779	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Epirubicin—thyroid cancer	0.000356	0.000776	CcSEcCtD
Gadofosveset trisodium—Anorexia—Doxorubicin—thyroid cancer	0.000352	0.000768	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Epirubicin—thyroid cancer	0.000351	0.000766	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Epirubicin—thyroid cancer	0.000347	0.000757	CcSEcCtD
Gadofosveset trisodium—Hypotension—Doxorubicin—thyroid cancer	0.000345	0.000753	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000345	0.000751	CcSEcCtD
Gadofosveset trisodium—Fatigue—Epirubicin—thyroid cancer	0.000344	0.00075	CcSEcCtD
Gadofosveset trisodium—Pain—Epirubicin—thyroid cancer	0.000341	0.000744	CcSEcCtD
Gadofosveset trisodium—Constipation—Epirubicin—thyroid cancer	0.000341	0.000744	CcSEcCtD
Gadofosveset trisodium—Paraesthesia—Doxorubicin—thyroid cancer	0.000332	0.000723	CcSEcCtD
Gadofosveset trisodium—Dyspnoea—Doxorubicin—thyroid cancer	0.000329	0.000718	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Epirubicin—thyroid cancer	0.000329	0.000717	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000326	0.000712	CcSEcCtD
Gadofosveset trisodium—Dyspepsia—Doxorubicin—thyroid cancer	0.000325	0.000709	CcSEcCtD
Gadofosveset trisodium—Decreased appetite—Doxorubicin—thyroid cancer	0.000321	0.0007	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000319	0.000695	CcSEcCtD
Gadofosveset trisodium—Fatigue—Doxorubicin—thyroid cancer	0.000318	0.000694	CcSEcCtD
Gadofosveset trisodium—Urticaria—Epirubicin—thyroid cancer	0.000317	0.000691	CcSEcCtD
Gadofosveset trisodium—Constipation—Doxorubicin—thyroid cancer	0.000316	0.000689	CcSEcCtD
Gadofosveset trisodium—Pain—Doxorubicin—thyroid cancer	0.000316	0.000689	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Epirubicin—thyroid cancer	0.000315	0.000688	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Epirubicin—thyroid cancer	0.000315	0.000688	CcSEcCtD
Gadofosveset trisodium—Feeling abnormal—Doxorubicin—thyroid cancer	0.000304	0.000664	CcSEcCtD
Gadofosveset trisodium—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000302	0.000659	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Epirubicin—thyroid cancer	0.000294	0.000641	CcSEcCtD
Gadofosveset trisodium—Urticaria—Doxorubicin—thyroid cancer	0.000293	0.00064	CcSEcCtD
Gadofosveset trisodium—Body temperature increased—Doxorubicin—thyroid cancer	0.000292	0.000637	CcSEcCtD
Gadofosveset trisodium—Abdominal pain—Doxorubicin—thyroid cancer	0.000292	0.000637	CcSEcCtD
Gadofosveset trisodium—Asthenia—Epirubicin—thyroid cancer	0.000286	0.000625	CcSEcCtD
Gadofosveset trisodium—Pruritus—Epirubicin—thyroid cancer	0.000282	0.000616	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Epirubicin—thyroid cancer	0.000273	0.000596	CcSEcCtD
Gadofosveset trisodium—Hypersensitivity—Doxorubicin—thyroid cancer	0.000272	0.000593	CcSEcCtD
Gadofosveset trisodium—Asthenia—Doxorubicin—thyroid cancer	0.000265	0.000578	CcSEcCtD
Gadofosveset trisodium—Dizziness—Epirubicin—thyroid cancer	0.000264	0.000576	CcSEcCtD
Gadofosveset trisodium—Pruritus—Doxorubicin—thyroid cancer	0.000261	0.00057	CcSEcCtD
Gadofosveset trisodium—Vomiting—Epirubicin—thyroid cancer	0.000254	0.000553	CcSEcCtD
Gadofosveset trisodium—Diarrhoea—Doxorubicin—thyroid cancer	0.000253	0.000551	CcSEcCtD
Gadofosveset trisodium—Rash—Epirubicin—thyroid cancer	0.000252	0.000549	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Epirubicin—thyroid cancer	0.000251	0.000548	CcSEcCtD
Gadofosveset trisodium—Headache—Epirubicin—thyroid cancer	0.00025	0.000545	CcSEcCtD
Gadofosveset trisodium—Dizziness—Doxorubicin—thyroid cancer	0.000244	0.000533	CcSEcCtD
Gadofosveset trisodium—Nausea—Epirubicin—thyroid cancer	0.000237	0.000517	CcSEcCtD
Gadofosveset trisodium—Vomiting—Doxorubicin—thyroid cancer	0.000235	0.000512	CcSEcCtD
Gadofosveset trisodium—Rash—Doxorubicin—thyroid cancer	0.000233	0.000508	CcSEcCtD
Gadofosveset trisodium—Dermatitis—Doxorubicin—thyroid cancer	0.000233	0.000507	CcSEcCtD
Gadofosveset trisodium—Headache—Doxorubicin—thyroid cancer	0.000231	0.000505	CcSEcCtD
Gadofosveset trisodium—Nausea—Doxorubicin—thyroid cancer	0.000219	0.000478	CcSEcCtD
